TABLE 7.

Top 10 most cited publications on APS.

Rank	Title	First author	Journal	Year	Total citation
1	The pathogenesis of the antiphospholipid syndrome	Giannakopoulos, B	New England Journal of Medicine	2013	394
2	EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome	Andreoli, L	Annals of the Rheumatic Diseases	2017	334
3	Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1,000 patients	Cervera, R	Annals of the Rheumatic Diseases	2015	329
4	Rivaroxaban vs. warfarin in high-risk patients with antiphospholipid syndrome	Pengo, V	Blood	2018	311
5	EULAR recommendations for the management of antiphospholipid syndrome in adults	Tektonidou, MG	Annals of the Rheumatic Diseases	2019	297
6	Guidelines on the investigation and management of antiphospholipid syndrome	Keeling, D	British Journal of Haematology	2012	288
7	Diagnosis and management of the antiphospholipid syndrome	Garcia, D	New England Journal of Medicine	2018	270
8	The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome	Rosario, C	BMC Medicine	2013	266
9	Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial	Cohen, H	Lancet Haematology	2016	225
10	Antiphospholipid syndrome	Schreiber, K	Nature Reviews Disease Primers	2018	215

Rank: based on the citation count.